Zhong W, Dai B
Hua Xi Yi Ke Da Xue Xue Bao. 1991 Sep;22(4):344-7.
SOKT1 -RTA immunotoxin, which consisted of an anti-pan-T cell monoclonal antibody SOKT1 and ricin toxin A-chain, decreased the peripheral blood lymphocyte transformation in response to PHA and to alloantigen by 92.9% and 84.7%, respectively. The generation of allocytotoxic T cell was also dramatically inhibited by this immunotoxin. After treatment of human bone marrow mononuclear cells with the immunotoxin, erythroid proliferation in CFU-E test preserved 62.9%. Based on these findings, we concluded that SOKT1-RTA immunotoxin can effectively inactivate human T lymphocytes in vitro without serious toxic effect on the hematopoietic progenitor cells. It may be an effective agent in aGVHD prophylaxis.
SOKT1-RTA免疫毒素由抗全T细胞单克隆抗体SOKT1和蓖麻毒素A链组成,它使外周血淋巴细胞对PHA和同种异体抗原的转化反应分别降低了92.9%和84.7%。这种免疫毒素也显著抑制了同种细胞毒性T细胞的产生。用该免疫毒素处理人骨髓单个核细胞后,CFU-E试验中的红系增殖保留了62.9%。基于这些发现,我们得出结论,SOKT1-RTA免疫毒素可在体外有效灭活人T淋巴细胞,而对造血祖细胞无严重毒性作用。它可能是预防急性移植物抗宿主病的有效药物。